Attached files
| file | filename |
|---|---|
| S-1 - S-1 - Patheon N.V. | s000936x1_s1.htm |
| EX-23.2 - EXHIBIT 23.2 - Patheon N.V. | s000936x1_ex23-2.htm |
| EX-99.2 - EXHIBIT 99.2 - Patheon N.V. | s000936x1_ex99-2.htm |
| EX-23.1 - EXHIBIT 23.1 - Patheon N.V. | s000936x1_ex23-1.htm |
| EX-99.5 - EXHIBIT 99.5 - Patheon N.V. | s000936x1_ex99-5.htm |
| EX-99.6 - EXHIBIT 99.6 - Patheon N.V. | s000936x1_ex99-6.htm |
| EX-99.3 - EXHIBIT 99.3 - Patheon N.V. | s000936x1_ex99-3.htm |
| EX-99.4 - EXHIBIT 99.4 - Patheon N.V. | s000936x1_ex99-4.htm |
| EX-99.1 - EXHIBIT 99.1 - Patheon N.V. | s000936x1_ex99-1.htm |
Exhibit 23.3
CONSENT OF INDEPENDENT AUDITORS
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 4, 2015 with respect to the combined financial statements of DSM Pharmaceutical Products Group included in this Registration Statement (Form S-1) and related Prospectus of Patheon Holdings Coöperatief U.A. for the registration of shares of its common stock.
/s/ Ernst & Young Accountants LLP
Maastricht, Netherlands
June 4, 2015